Annual Total Long Term Liabilities
$2.07 M
+$2.07 M+100.00%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual total long term liabilities is currently $2.07 million, with the most recent change of +$2.07 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$2.07 million (+100.00%). BLACU annual total long term liabilities is now at all-time high.BLACU Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$2.07 M
$0.000.00%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly total long term liabilities is currently $2.07 million, unchanged on 30 September 2024. Over the past year, it has stayed the same.BLACU quarterly long term liabilities is now at all-time high.BLACU Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | 0.0% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | - | - |
BLACU Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | at high | ||
| 5 y | 5 years | at high | at high | ||
| alltime | all time | at high | at high |
Bellevue Life Sciences Acquisit Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.07 M(0.0%) |
| June 2024 | - | $2.07 M(0.0%) |
| Mar 2024 | - | $2.07 M(0.0%) |
| Dec 2023 | $2.07 M | $2.07 M(0.0%) |
| Sept 2023 | - | $2.07 M(0.0%) |
| June 2023 | - | $2.07 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.07 M(>+9900.0%) |
| Dec 2022 | $0.00(0.0%) | - |
| Dec 2022 | - | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00 |
| Dec 2020 | $0.00 | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual total long term liabilities?
- What is the all time high annual total long term liabilities for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual total long term liabilities year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly long term liabilities year-on-year change?
What is Bellevue Life Sciences Acquisit annual total long term liabilities?
The current annual total long term liabilities of BLACU is $2.07 M
What is the all time high annual total long term liabilities for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual total long term liabilities is $2.07 M
What is Bellevue Life Sciences Acquisit annual total long term liabilities year-on-year change?
Over the past year, BLACU annual total long term liabilities has changed by +$2.07 M (+100.00%)
What is Bellevue Life Sciences Acquisit quarterly total long term liabilities?
The current quarterly long term liabilities of BLACU is $2.07 M
What is the all time high quarterly long term liabilities for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly total long term liabilities is $2.07 M
What is Bellevue Life Sciences Acquisit quarterly long term liabilities year-on-year change?
Over the past year, BLACU quarterly total long term liabilities has changed by $0.00 (0.00%)